Similar Jobs
It’s More Than a Career, It’s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
Summary
The Senior Product Analyst – Digital Transformation plays a pivotal role in advancing SCRI’s digital vision by translating strategic priorities into actionable business and technology solutions. Reporting to the Director of Digital Transformation, this role bridges business stakeholders and IT delivery teams to design, implement, and validate digital solutions that enhance efficiency, data integrity, and innovation across HR, Finance, IT, and Quality functions. This position demands a strong mix of analytical acumen, technical fluency, and business process understanding to ensure that enterprise and functional initiatives are executed with precision, scalability, and measurable impact.
Duties and Responsibilities
Collaborate with stakeholders and IT to elicit, document, and prioritize requirements for digital transformation
Translate strategies into user stories, workflows, and specifications for automation and process optimization
Work with product owners and developers to align solutions with enterprise data and AI strategies
Support change management, documentation, and user enablement for sustained adoption
Knowledge
Deep understanding of clinical trial and corporate systems (CTMS, Veeva Vault, SAP, ServiceNow, SmartSolve) and their integration
Familiarity with AI-enabled automation, data analytics, and digital tools for enterprise functions
Knowledge of Agile/Scrum, SDLC, and clinical research regulatory requirements
Awareness of data governance, interoperability, and compliance in life sciences
Understanding of digital adoption analytics and generative AI applications
Skills
Advanced analytical and problem-solving skills for process optimization
Proficiency with business analysis and project management tools (Jira, Confluence, Planview, Smartsheets)
Strong communication skills to convey technical details to business audience
Skilled in requirements traceability, cross-functional alignment, and test validation
Ability to measure and present digital ROI through data-driven storytelling
Experience with process-mining and AI-driven workflow analysis to identify automation and optimization opportunities
Abilities
Connects strategy to operational execution, ensuring vision becomes reality
Collaborates effectively with executives, product owners, and developers
Adapts and applies emerging digital and AI technologies to improve processes
Thrives in fast-paced, cross-functional environments with multiple priorities
Committed to continuous learning, quality, and innovation
Experience
3–5+ years as a product or business analyst with a strategic consultant mindset to enable digital transformation in a dynamic environment
Proven support for healthcare product development with cross-functional teams and external partners
Strong analytical skills to identify business challenges and drive project outcomes while effectively communicating with leadership on milestones
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
